Skip to content

As ketogenic therapy gains momentum in treating neuropsychiatric disorders, we asked Stanford Medicine’s expert Shebani Sethi for the key takeaways.

As ketogenic therapy gains momentum in treating neuropsychiatric disorders, we asked Stanford Medicine’s expert Shebani Sethi for the key takeaways.

Published on

As artificial intelligence pervades health and medicine, researchers have developed a new evaluation framework to help scientists determine which type of algorithms are best suited for health care.

As artificial intelligence pervades health and medicine, researchers have developed a new evaluation framework to help scientists determine which type of algorithms are best suited for health care.

Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.

Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.

Published on